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Abstract
Background: Publications worldwide have reported on the re-occurrence of human enterovirus 68 (EV68), a rarely detected
pathogen usually causing respiratory illness. However, epidemiological data regarding this virus in particular on the Asian
continent has so far been limited.
Methodology/Findings: We investigated the epidemiology and genetic variability of EV68 infection among Thai children
with respiratory illnesses from 2006–2011 (n=1810). Semi-nested PCR using primer sets for amplification of the 59-
untranslated region through VP2 was performed for rhino-enterovirus detection. Altogether, 25 cases were confirmed as
EV68 infection indicating a prevalence of 1.4% in the entire study population. Interestingly, the majority of samples were
children aged .5 years (64%). Also, co-infection with other viruses was found in 28%, while pandemic H1N1 influenza/2009
virus was the most common co-infection. Of EV68-positive patients, 36% required hospitalizations with the common clinical
presentations of fever, cough, dyspnea, and wheezing. The present study has shown that EV68 was extremely rare until
2009 (0.9%). An increasing annual prevalence was found in 2010 (1.6%) with the highest detection frequency in 2011 (4.3%).
Based on analysis of the VP1 gene, the evolutionary rate of EV68 was estimated at 4.93610
23 substitutions/site/year. Major
bifurcation of the currently circulating EV68 strains occurred 66 years ago (1945.31 with (1925.95–1960.46)95% HPD).
Among the current lineages, 3 clusters of EV68 were categorized based on the different molecular signatures in the BC and
DE loops of VP1 combined with high posterior probability values. Each cluster has branched off from their common
ancestor at least 36 years ago (1975.78 with (1946.13–1984.97)95% HPD).
Conclusion: Differences in epidemiological characteristic and seasonal profile of EV68 have been found in this study. Results
from Bayesian phylogenetic investigations also revealed that EV68 should be recognized as a genetically diverse virus with a
substitution rate identical to that of enterovirus 71 genotype B (4.2610
23 s/s/y).
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Introduction
Human enterovirus 68 (EV68) is a sporadically detected viral
pathogen associated with respiratory tract illnesses. EV68 belongs
to the family Picornaviridae which contains socially and economi-
cally important pathogenic viruses such as foot-and-mouth disease
virus, human enterovirus, rhinovirus, and hepatitis A virus. It has
been classified in the genus Enterovirus species D which currently
comprises 2 important human pathogens, EV serotype 70 and
serotype 94. It possesses a positive single-stranded RNA genome of
,7.5 kb in length encased by a highly structured icosahedral
capsid. The viral genome is composed of a 59-untranslated region
(59UTR) followed by a long single open reading frame and
terminated by a short 39UTR with genetically encoded poly-A
tract. The coding sequence is co-translationally processed by a
virus encoded protease to yield 4 structural (viral capsid protein
(VP)-1 to VP4) and 7 nonstructural proteins (2A to 2C and 3A to
3D) which are responsible for viral replication, protein processing
and also contribute to shutting down the host cell’s protein
production.
Many methods have been established for EV typing. Normally,
traditional methods rely on biological properties of the viruses such
as antigen distinction which subdivides EV into ‘serotypes’.
However, this method is time consuming, expensive, and could
not classify some newly identified EVs. Consequently, as
alternative and sensitive methods of classification of all EVs,
reverse transcription polymerase chain reaction (RT-PCR) and
nucleotide sequencing of the entire genome or partial VP4 or
VP4/VP2 regions combined with the results from VP1 gene have
recently been utilized for characterizing EVs [1–4]. EV68 was
originally isolated in California in 1962 from children with
pneumonia and bronchiolitis by using virus isolation and sero-
neutralization approaches [5]. In contrast to other EVs, EV68
shares common biological properties with human rhinovirus (RV),
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temperature of ,33uC [6,7]. The virus is usually found
predominantly in respiratory illness patients. Infection by this
virus can cause various disease severities ranging from mild
respiratory illnesses such as common cold to severe acute lower
respiratory tract infections (ALRTI) including pneumonia, wheez-
ing and bronchiolitis [8–11]. Three fatal cases caused by severe
respiratory illnesses and associated with EV68 infection have been
reported [10,11]. Recent studies have suggested that asthmatic
individuals infected with EV68 have a propensity to develop
unstable asthma or an acute attack [9]. Despite the medical
burden of the disease, no effective antiviral therapies have been
approved for either prevention or treatment of EV68 infection.
Awareness of its precise global distribution, longitudinal epidemi-
ological profiles, its pathogenic role, and evolutionary history of
EV68 are also still lacking. Furthermore, since the re-occurrence
of EV68 infection in several countries worldwide [8], only 3
epidemiological studies of EV68 have been reported from the
Asian continent (2 from Japan during the study periods of 2006–
2009 and 2009–2010 and 1 from the Philippines during 2009–
2010) [9–11].
To address these concerns, we conducted a prospective
longitudinal population-based study among Thai children aged
15 years (yrs.) and below with acute respiratory tract illness (ARTI)
symptoms during 2006–2011. Semi-nested PCR amplification
covering a highly conserved 59UTR up to and including the 59
terminus of the capsid VP2 gene (59UTR/VP2) and nucleotide
sequencing were applied to elucidate many aspects of the
epidemiology and evolution of the virus. The primary objective
was to determine whether EV68 infection was associated with
ARTI among a large number of children in Thailand. The
secondary objective was to better understand the evolutionary
history of EV68 circulating lineages and to determine how
evolution of this virus might have been shaped by its population
dynamics.
Results
Study Population
We retrospectively analyzed 1822 stored respiratory specimens
obtained from 1785 children with ARTI complications who visited
several hospitals located in Bangkok, Thailand between February
14, 2006 and November 8, 2011. The main characteristics of these
populations are summarized in Table 1. Of these eligible
specimens, 24 originated from 12 children and collected in the
course of the same hospitalization for treatment follow-up.
Twenty-five children had multiple hospitalizations; 22 had 2
admissions and 3 had 3 admissions. Therefore, a total of 1810
respiratory specimens were available for testing.
To assess the distribution of respiratory virus infection with
regard to the specific children’s age and severity of respiratory
illness, the subjects were categorized into 4 groups as follows:
infant (#2 yrs.), pre-school (.2 to 5 yrs.), primary-school (.5t o
12 yrs.), and secondary school children (.12 to 15 yrs.). Of 1810
cases, 26 cases (1.4%; 14 outpatients and 12 hospitalized patients)
could not provide specific information with regards to age, 39.2%
were infants (n=709), 23.2% were pre-school (n=420), 26.5%
were primary-school (n=480), and 9.7% were secondary school
children (n=175) (Table 1). The age distribution of enrolled
patients was between 1 day (d.) to 15 yrs. Clinical severity of ARTI
cases was defined as follows: pediatric patient with ARTI
complications not requiring hospitalization and O2 supplementa-
tion and normal to slightly increased respiratory rate was defined
as ‘mild’ case, patient with ARTI symptoms, requiring hospital-
ization, and either did or did not require supplemental O2 was
defined as ‘moderate’ case, patient with severe respiratory failure
with O2 saturation ,90%, requiring medical ventilation or O2
supplementation, and admission to the Intensive Care Unit (ICU)
was defined as ‘severe’ case. Consequently, 32.1% (n=581), and
0.9% (n=16) of the entire study population were considered as
moderate and severe cases, respectively, while the remaining cases
were mild ARTIs (67%; n=1213).
Detection of EV68 in ARTI Patients
Of children with ARTI complications, 812 were infected by at
least 1 respiratory virus accounting for 44.9% of all enrolled cases.
Rhino-enterovirus (RV-EV) was detected in 15.9% (288/1810).
Among these, 25 were confirmed as EV68 infection accounting for
8.7% of RV-EV positive specimens and indicating a prevalence of
1.4% in the entire study population. To investigate the relation-
ship between EV68 characterized in Thailand (EV68-TH strains)
and the previously defined strains, phylogenetic tree of the
59UTR/VP2 region (Fig 1A) and their sequence identity matrix
(Table 2) were constructed. The 59UTR/VP2 region of EV68-TH
strains exhibited 86.3–97.1% nucleotide identities to each other.
EV68-TH strains shared 71–84.1% nucleotide identity with the
first identified strain ‘Fermon’ (AY426531) and 67.7–93.7% with
those of strains identified from other countries. All EV68 infected
cases were confirmed by amplification of the VP1 gene. Despite
performing semi-nested PCR and nested-PCR amplifications
yielding a 2
nd PCR product of ,850, 450 or 250 nucleotides
(nt), only 11/25 EV68-positive specimens could be amplified.
Fig 1B shows the phylogenetic tree of the capsid VP1 encoding
gene. Comparisons of the nucleotide sequence of VP1 revealed
84.4–100% identity among EV68-TH strains and 81.7–92.2%
identity between TH-strains and the primary strains. The TH-
strains shared 85.6–99.8% nucleotide identity with the EV68
strains currently circulating or identified between 2008 and 2010.
Table 1. Main characteristics of the study populations and respiratory specimens.
Years of study Sample N Infant Pre-school Primary school Secondary school
Feb 2006–Jul 2008 NP 383 318 (0.9+0.5) 42 (3.5+0.7) 14 (8.9+2.1) 4 (13.5+0.5)
Jun 2009–Sep 2011 NS 1213 238 (1.5+0.6) 352 (4.3+0.8) 442 (8.7+1.9) 167 (14.6+0.9)
Jul 2010–Nov 2011 NP 214 153 (1.1+0.7) 26 (3.7+0.9) 24 (8.5+1.9) 4 (13.3+0.4)
Total 1810 709 420 480 175
Patient age, yrs 1.1+0.6 3.3+0.7 8.7+1.9 14+0.9
NP, Nasopharyngeal aspiration specimens; NS, Posterior oropharyngeal and nasal swab specimens.
Patient age was showed by using mean 6 standard deviation.
doi:10.1371/journal.pone.0035190.t001
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positive children are summarized in Table 3.
Results from RV-EV specific PCR amplification and nucleotide
sequencing also revealed that 15 specimens had other EV
infections (Fig 1A). Of these, 1 specimen was classified as
poliovirus Sabin-2 with similar proportions of poliovirus Sabin-3
(vaccine strains confirmed), coxsackie virus (CA)-A9, echovirus 9,
echovirus 6, and EV109 whereas CA-B5 and CA-B2 were
identified in 2 samples each. Five samples were positive for CA-
A24. The overall frequency of detection was 0.8% (15/1810).
Clinical Manifestations of EV68 Infected Patients
EV68 were detected as a sole pathogen in 16/25 cases (64%).
Co-infections by other respiratory viruses were found in 9 cases
(36%) including 1 with respiratory syncytial virus (RSV) type A, 3
with influenza B virus (Flu-B), and the remaining 5 patients were
co-infected with pandemic H1N1/2009 virus (pH1N1/2009). As
shown in Table 4, age specifics of children with ARTI
complications were 1% infant (7 cases; 1 outpatient and 6
hospitalized patients), 2% pre-school (2 cases; all were hospitalized
cases), 2.1% primary-school (10 cases; 9 outpatients and 1
hospitalized patient), and 3.4% secondary school children (6 cases;
all were outpatients). The average age of EV68-associated ARTI
cases was statistically higher than that of the non-infected group
(7.6+5.0 yrs. vs 5.0+4.4 yrs.; p=0.04). Without co-infection by
other pathogens, the average age of EV68-associated ARTIs was
5.8+4.4 yrs. The majority of EV68 cases were primary school
(40% of EV68 cases and 2.1% of primary school cases) and
secondary-school children (24% of EV68 cases and 3.4% of
secondary-school cases). Of EV68-positive children, 64% were
children aged .5 yrs. (p=0.016). Female-to-male ratio of EV68
infected patients was 1.5:1. As for the contribution of the virus to
disease severity, the majority of positive cases had moderate
severity (32% (8/25)). One patient presented with severe clinical
characteristics and required admission to the ICU. EV68-
associated ARTI represented 6.3% (1/16) of all severe cases.
Figure 1. Neighbor-joining (NJ) estimate of phylogenetic relationship for human enteroviruses detected among Thai pediatric
children during 2006–2011. The NJ trees were constructed from nucleotide alignments of (A) the 59UTR/VP2 (612 nt) and (B) partial VP1 region
(257 nt) using MEGA software. The genetic distances were calculated according to the Kimura-parameter model. Bootstrap support values with 1000
pseudo-replicates were plotted at the internal branch nodes. EV species A to D were labeled. Period of the sample collection was plotted for each
lineage. EV68 and other EVs identified in this study (TH-strain) are indicated in black and white circles, respectively. Virus sequence names or location
of isolations shown with GenBank accession numbers were reference strains. Scale bar indicates number of nucleotide substitutions per site.
doi:10.1371/journal.pone.0035190.g001
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patients with ARTI were more likely to be infected with EV68
compared to outpatients (1.5% (9/597) vs 1.3% (16/1213)) but this
difference did not show any statistical significance. Summary of
discharge diagnoses of EV68-confirmed cases included viral
pneumonia (n=8), asthma (n=1), and influenza-like illness (ILI)
(n=16). Clinical manifestations of the 9 hospitalized patients with
EV68 infections are summarized in table 5. Supplemental O2 and
Table 2. Nucleotide identity matrix obtained for the alignment of 5UTR9/VP2 region of EV68 identified from Thailand and
reference strains of EV68 and other members of enterovirus species D (EV94 and EV70).
Sequence CU134 CU54 B2054 B2060 B1512 B196 EV94 JPOC FR3799 Fermon
CU54 86.2
B2054 99.6 85.8
B2060 99.8 86.0 99.4
B1512 88.0 92.3 87.7 87.9
B196 99.1 85.3 98.7 98.9 87.5
EV94 68.6 70.7 68.6 68.4 69.6 67.9
JPOC 93.5 86.9 93.2 93.4 88.7 93.0 67.7
FR3799 93.9 89.7 93.5 93.7 91.8 93.0 68.6 94.6
Fermon 82.9 82.8 82.6 82.8 84.1 82.4 71.0 82.9 82.9
EV70 71.8 70.8 71.8 71.6 70.1 70.9 75.2 69.1 69.6 70.7
The GenBank accession numbers of the previously published sequences are as follows: EV94, EF107097; EV70, NC_001430; JPOC, AB601884; FR3799, EF107098; Fermon,
AY426531.
doi:10.1371/journal.pone.0035190.t002
Table 3. Clinical characteristics and demographic data of the 25 cases of EV68 infection.
Strain Sample Date Age Sex Co-infection Diagnosis 59UTR/VP2 VP1
TH-B196 NS 30/6/2009 13 M pH1N1/2009 ILI JQ411799 N/A
TH-B211 NS 1/7/2009 14 F pH1N1/2009 ILI JQ411798 N/A
TH-B323 NS 4/7/2009 11 F pH1N1/2009 ILI JQ411797 N/A
TH-B521 NS 9/7/2009 10 M pH1N1/2009 ILI JQ411796 N/A
TH-B1512 NS 2/9/2009 15 F – ILI JQ411794 JQ411802
TH-B2054 NS 9/2/2010 12 M pH1N1/2009 ILI JQ411791 N/A
TH-B2060 NS 10/2/2010 8 F – ILI JQ411792 N/A
TH-B2114 NS 16/2/2010 9 M – ILI JQ411789 N/A
TH-B2192 NS 24/2/2010 9 F – ILI JQ411793 N/A
TH-B2213 NS 26/2/2010 8 F – ILI JQ411790 N/A
TH-B2303 NS 12/3/2010 14 M – ILI JQ411786 N/A
TH-B2340 NS 1/4/2010 6 M – ILI JQ411788 N/A
TH-B2370 NS 2/6/2010 14 M Flu-B ILI JQ411787 N/A
TH-B3611 NS 15/9/2010 15 F Flu-B ILI JQ411781 N/A
TH-B4105 NS 5/10/2010 6 F Flu-B ILI JQ411782 N/A
TH-B4790 NS 27/6/2011 1 F – ILI JQ411785 JQ411809
TH-CU54 NP 8/7/2011 2 F – VP JQ411783 JQ411805
TH-CU70 NP 25/7/2011 1 F – VP JQ411784 JQ411801
TH-CU101 NP 15/8/2011 2 F – VP JQ411776 JQ411804
TH-CU110 NP 18/8/2011 2 F RSV-A VP JQ411777 JQ411810
TH-CU115 NP 22/8/2011 4 F – VP JQ411778 JQ411811
TH-CU124 NP 26/8/2011 7 F – VP JQ411779 JQ411807
TH-CU134 NP 31/8/2011 2 M – VP JQ411775 JQ411803
TH-CU151 NP 12/9/2011 4 M – VP JQ411780 JQ411806
TH-CU171 NP 23/9/2011 7 m M – VP JQ411795 JQ411808
pH1N1/2009, pandemic influenza A virus subtype H1N1/2009; Flu-B, Influenza B virus; RSV, Respiratory syncytial virus; ILI, influenza like illness; VP, Viral pneumonia.
doi:10.1371/journal.pone.0035190.t003
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The most common clinical characteristics of these patients were
fever, cough and dyspnea (77.8%), and wheezing (66.7%).
Hospitalization lasted a median of 5 d (ranging from 3–16 d).
Four patients with EV68 infections had no medical history while 3
had underlying disease such as gastro-esophageal reflux, congen-
ital heart disease, and autism and 2 had a history of asthma. One
of these had RSV-A co-infection in the nasal aspiration specimen.
However, there was no significant difference in disease severity
between the case with and without RSV co-infection.
Seasonality of EV68 Infections
During the first 2 years (February 2006–July 2008), there was no
EV68 infection in the sample population (n=383). Fig 2 provides
epidemiological profile of EV68 infection among the patient
samples identified in Thailand during 2009–2011. In 2009, 5
EV68 cases were detected in June, July, and September (rainy
season) with 0.9% annual prevalence (5/584; all were outpatients).
Increased incidence of EV68 infection associated with ARTI was
found in 2010 and 2011. In 2010, the virus could be found during
a 6-month period with 1.6% annual prevalence (10/611; all were
outpatients). During 2011, EV68 infections were investigated only
during the rainy season with 4.3% annual prevalence (10/232; 1
was outpatient and 9 were hospitalized patients). Of all EV68
infections detected, 8% were identified from ARTI children
admitted to the hospital in summer, 72% during the rainy season,
and 20% in winter. Among the meteorological factors, relative
humidity was the only factor statistically correlated with the overall
number of RV-EV infected patients particularly in 2011
(correlation coefficient (rs)=0.61, p=0.04). None of the meteoro-
logical factors correlated with the frequency of EV68 detection in
Thailand.
Substitution Rate and Evolutionary Timescale of
Circulating EV68 Strains
Evolutionary rates for VP1 gene were measured as the number
of nucleotide substitutions per site per year (s/s/y). By using the
Bayesian Markov chain Monte Carlo (MCMC) method, the
overall evolutionary rate of the VP1 gene of the entire EV68
sequence dataset (dataset 2) was estimated at 4.93610
23 s/s/y
with a 95% HPD limit of 4.01–5.85610
23 s/s/y. The evolution-
ary rate was lower (3.2610
23 s/s/y with a 95% HPD of 2.27–
4.25610
23 s/s/y) when the values were calculated with dataset 1
including a more homologous sampling timescale of all EV
species. According to our analysis of the evolutionary timescale of
EV68-VP1 sequences (Fig 3), the major bifurcation of the
currently circulating EV68 strains from their first isolated
prototype (Fermon) occurred 66 years ago (time 1945.31 with
(1925.95–1960.46)95% HPD). Based on molecular signature
analysis of the BC and DE surface loops of the viral determinant
VP1 protein, 3 clusters of EV68 were categorized with the
posterior probability (pp) value of 1 for clusters 1 and 2, and pp of
0.93 for cluster 3 (Fig 4). The date when each cluster branched off
from the most common recent ancestor (TMRCA) occurred in the
1970s (1975.78, (1946.13–1984.97)95% HPD). Furthermore,
EV68 seems to have diverged from their TMRCA with EV
species D 198 years ago (1813.42 with (1676.61–1920.46)95%
HPD) and with EV species A 680 years ago (1328.09 with
(918.20–1694.19)95% HPD).
Selective Pressure on EV68
To evaluate the adaptive molecular evolution of EV68, overall
selective pressure operating on the determinant encoding VP1 was
examined by estimating the ratio of non-synonymous (dN)t o
synonymous (dS) substitutions (v=d N/dS) across the lineages on a
codon by codon basis. Selective pressure was defined as follows:
v=1 indicates neutral evolution, v ,1 indicates purifying or
negative selection, and v .1 indicates positive selection. The
overall v value of the VP1 region was 0.091. The majority of
amino acid residues in the VP1 region had v ,1 indicating that
the amino acids in the antigenic determinant were under purifying
selection. To determine whether any specific site or residue of the
VP1 region evolved under positive selection, the two rate fixed
effects likelihood (FEL) and single likelihood ancestor counting
(SLAC) methods were applied. Results from FEL method revealed
that codon position 23, 78, 86, 91, 93, 172, 212 and 237 displayed
v.1 without statistical significance. Codon positions 86 and 237
displayed 1.191 and 1.372 normalized dN–dS values, respectively.
However, codon position 237 was the only residue that
significantly evolved under positive selection (p=0.046). The v
values per codon site across the partial VP1 region of EV68 are
shown in Fig 5. The dominant amino-acid compositions at the
alignment positions of BC and DE-surface loops of EV68 are
showed in Fig 6.
Discussion
Our longitudinal study investigated the prevalence and clinical
characteristics of EV68 infection among Thai children with ARTI
who visited various hospitals in Bangkok during 2006–2011. In
recent years, with the use of highly sensitive molecular techniques,
sporadically detected EV68 virus has been recognized as a re-
emerging respiratory pathogen in several countries worldwide
since it has been detected with higher frequency in 2008 [8,12].
EV68 is becoming an increasingly important etiological agent as it
was the only pathogen identified in respiratory specimens obtained
from fatal cases reported in the retrospective studies of the
Philippines and Japan [10,11]. In the present study, the 25
episodes of EV68 infection associated with ARTI were investigat-
Table 4. ARTI cases infected by EV68 in Thailand from June 2009 to November 2011.
Group Mild ARTI Moderate ARTI Severe ARTI EV68 cases Average age
Infant (n=709) 1 (0.1%) 5 (0.9%) 1 (6.3%) 7 (1%) 1.5+0.7
Pre-school (n=420) 0 2 (0.3%) 0 2 (0.5%) 4
Primary-school (n=480) 9 (0.7%) 1 (0.2%) 0 10 (2.1%) 8.6+2.0
Secondary-school (n=175) 6 (0.5%) 0 0 6 (3.4%) 14.2+0.8
Total 16 (1.3%) 8 (1.4%) 1 (6.3%) 25
Average age=mean 6 standard deviation.
doi:10.1371/journal.pone.0035190.t004
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evaluating nucleotide sequences of the region encompassing part
of the 59UTR/VP2 and VP1 gene. Our results suggested that
children above the age of 5 yrs. seem to be specifically targeted by
EV68. Other studies also reported a similar correlation between
patient’s age distribution and frequency of EV68 infection [8–
11,13,14]. Despite EV68 infections generally affecting younger
children, the association between virus infections and respiratory
illnesses in adult patients has also been established [12,13,15]. In
concurrence with the earlier reports, infection by this virus appears
to be an important cause of viral pneumonia in children requiring
hospitalization with common clinical presentations of fever, cough,
dyspnea, and wheezing [10,12,13]. Among children with a history
of asthma who experienced more severe asthma attacks, EV68 was
the sole etiological agent detected indicating its role as an
aggravating factor to severe persistent respiratory disease.
Furthermore, a strong association of asthma exacerbation and
the virus infection has also been reported [9].
Historically, EV68 has been regarded as an uncommon
pathogen associated with respiratory illness. However, until now,
the full spectrum of illness caused by the infection of this virus has
remained unclear. The involvement of EV68 in central nervous
system disease has been reported by various US research teams.
Khetsuriani et al. discovered the virus from an acute flaccid
paralysis case in 2005 [14], while the other group found the virus
in cerebrospinal fluid samples taken from fatal meningomyeloen-
cephalitis children in 2011 [16]. Further comparative population-
based studies which include other infectious diseases, healthy
controls, or adult hospitalized patients should be conducted to
elucidate the causal relationship between EV68 infection and
disease progression.
In Thailand, no epidemic status of EV68 infection has so far
been reported. Our results showed that EV68 probably emerged
in Thailand in 2009. Since that time, EV68 infected cases have
more frequently been detected during 2010 and, thus far,
displayed the highest prevalence in 2011. This finding supported
prior observations that the upsurge of EV68 infection has
apparently occurred on a global scale since 2010. Distinct seasonal
patterns of EV68 infection in ARTI patients were found in
Thailand during the study period. Infection rates were higher
during the rainy seasons of 2009 and 2011 while no seasonal
pattern was apparent in 2010. The variation in EV68-seasonal
profile examined in our study was similar to the profiles of
respiratory viruses in tropical countries with a higher average
temperature throughout the year and less changes in seasonal
temperature [17–20]. Other studies performed in temperate
climates observed seasonality of EV68 in the autumn seasons
(Japan 2010 [11], France [21], Netherlands [12], and Italy 2008
[22]). These observations suggested that the seasonal profile of
EV68 may vary by season, geographic location, and year.
The VP1 protein is the largest and most exposed surface capsid
protein containing the majority of motifs important for interaction
with neutralizing antibodies and the cellular receptor required for
Table 5. Summary of clinical manifestations and diagnoses of the 9 patients hospitalized with EV68 infection.
EV68 strain LT Underlying Symptom O2 therapy
TH-CU54 5 No Fever, cough, dyspnea, wheezing Yes
TH-CU70 3 No Fever, cough, dyspnea, wheezing Yes
TH-CU101 5 Autism Fever, cough, vomiting Yes
TH-CU110 4 No Fever, cough, vomiting, diarrhea, dyspnea, wheezing No
TH-CU115
a 4 No Tachypnea, wheezing, runny nose Yes
TH-CU124
a 7 No Fever, cough, dyspnea, wheezing Yes
TH-CU134 8 GER Fever, cough, dyspnea, wheezing Yes
TH-CU151 3 No Fever, cough, runny nose, dyspnea, wheezing Yes
TH-CU171
b 16 CHD cough, dyspnea, upper airway obstruction Yes
a = had history of asthma/b = admitted to the intensive care unit.
All of these EV68 infected patients required nebulizer.
LT, Length of hospitalization (days); GRE, Gastro-esophageal reflux; CHD, Congenital heart disease.
doi:10.1371/journal.pone.0035190.t005
Figure 2. Seasonal distribution of EV68 in Bangkok, Thailand
combined from 3 years (2009–2011) during which EV68 cases
had been reported. Bar graph shows percentage of pediatric patients
with EV68 infection and line graphs indicate monthly average
temperatures (degree Celsius (uC)) in Bangkok.
doi:10.1371/journal.pone.0035190.g002
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selective pressure influencing EV68 adaptation should be investi-
gated to provide a better understanding of the genetic diversity and
evolutionary relationship of EV68. Results obtained in the present
study suggested EV68 could be divided into 3 clusters based on
their phylogenetic relationship and the unique molecular signatures
within the BC and DE surface loops which was supported by high
values of posterior probability. Our suggestion also resembled
Meijer’s report [12]. Our study also inferred the rate of
evolutionary change for EV68 as 4.93610
23 s/s/y. This value is
in accordance with the evolutionary rates of other picornaviruses
such as EV71 genotype B (4.2610
23 s/s/y) [23,24]. In comparison
with other picornavirus members, the rate of evolutionary change
estimated for the determinant region of EV68 is faster than the
mean evolutionary rate of human parechovirus (2.8610
23 s/s/y)
[25], EV71 genotype C (3.4610
23 s/s/y) [24] and hepatitis A virus
(9.8610
24 s/s/y) [26] whereas it is lower than the rate of poliovirus
(3610
22 s/s/y) [27,28]. Consistently, the high evolutionary rate
among these viruses relies on several factors including replicase
fidelity, highly error prone viral RNA-dependent RNA polymer-
ases resulting in a misincorporation frequency of 1 per 10
3 to 10
4
nucleotides [29], rate of transmission, and any synonymous
mutations of viral proteins. These factors increase the number of
mutations incorporated in viral genomes overtime and prepare the
ground for rapid genetic diversification [30]. Moreover, intra- and
inter-serotype recombination is also believed to be a large-impact
evolutionary mechanism influencing the genetic and antigenic
diversity of enterovirus, poliovirus, and other picornaviruses [31–
40]. Our study also showed that purifying selection plays an
important part in shaping the evolution of EV68. This constrained
mutation of EV68 can be explained by the limited size and the
genetic architecture of the viral genome which is overlapping
between structural and functional domains [41–43]. With regard to
adaptive mutation of EV68 under serological selection, the v
values of specific residues in the VP1 were determined. The result
suggested that EV68 tends to escape from stabilizing selection by
positively mutating some residues in the antigenic epitope, in
particular the residue located on the surface BC and DE loops,
resulting in discrimination between the 3 distinct phylogenetic
lineages. Differences in the classification of EV68 have been
reported by Rahamat-Langendoen et al [13]. Two distinct
evolutionary lineages comprising old and new clusters were
Figure 3. Bayesian time-scale phylogeny of EV68 and other EVs based on the partial VP1 sequence analysis (dataset 1 containing
122 sequences with 723 nt in length). Maximum clade credibility tree obtained with BEAST with a constant size coalescent prior showing lineage
splitting events since the most recent common ancestor to the presently circulating EV68 strains. The divergence times correspond to the mean
posterior estimate of their ages. For the TMRCA, the correspondent 95% Bayesian credible intervals are shown. Time axis is shown in years and ranges
from the TMRCA to the present year.
doi:10.1371/journal.pone.0035190.g003
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e35190Figure 4. A maximum clade credibility tree from Bayesian timescale phylogenetic analysis of EV68 (dataset 2; n=106 sequences,
length=723 nt). The posterior probabilities and 95% HPD intervals of the key nodes are depicted above the respective nodes. Three major recent
clusters are marked by vertical lines.
doi:10.1371/journal.pone.0035190.g004
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VP2 and VP1 and year of identification. The old cluster comprised
EV68 strains identified in the Netherlands in 2009 and 2010. The
new cluster contained all 2010 strains and some of these strains had
one amino acid deletion in the VP1. Upon combining these
characteristics, the previously defined old and new groups could be
reclassified within cluster 1 and 2, respectively.
Figure 5. The ratio of nonsynonymous to synonymous substitutions (v=d N/dS) per codon site across the VP1 region of EV68. The
residue likely to have evolved under positive selection was recognized when the v value .1.0. Codon position assigned to this plot was based on the
position of the VP1 protein in the EV68 prototype, Fermon (AY426531).
doi:10.1371/journal.pone.0035190.g005
Figure 6. Relative residue abundance at the alignment positions of BC and DE surface-exposed loops. The graphical representation was
generated using WebLogo. The height of symbol indicates the relative frequency of the corresponding amino acid at that position. Residue positions
are given based on the nucleotide positions of the Fermon strain (AY426531).
doi:10.1371/journal.pone.0035190.g006
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collected since 2006 and utilizing sensitive PCR approaches, some
limitations need to be considered. First, it was possible to conclude
that ARTI associated with EV68 infection was first introduced to
Thailand in 2009 since EV68- infection was not found between
2006 and 2008. Nonetheless, the limited number of specimens
towards the end of 2008 and during the first 5 months of 2009
might be an obstacle to our conclusion. Second, although we
utilized specimens which we collected from several hospitals
located in many different regions, at least 80% of children were
Bangkok residents. Therefore, the enrolled children might not be
representative of the entire country population. Increased surveil-
lance together with improved laboratory diagnostic techniques will
help reveal epidemiology, clinical association, and relationship
between the evolutionary rate and the worldwide circulation of
this virus. Analyses at the genome level would also be required for
a better understanding of the role of selective pressure in this virus
evolution.
In conclusion, our study provides additional epidemiological
and clinical data on EV68 infection in Thailand indicating
worldwide re-emergence of this virus with variations in epidemi-
ological profile. Our data highlighted the potential importance of
EV68 as a causative agent of severe respiratory illness which
causes hospitalization in children with specific age distribution. We
also showed that purifying selection is the predominant evolution-
ary force acting on the capsid VP1 of EV68 in that some amino
acid residues on the surface exposed loops of the viral epitope are
positively selected for escape mutation.
Materials and Methods
Study Population and Sample Collection
Posterior oropharyngeal and nasal swabs specimens were
collected from non-hospitalized patients who had been diagnosed
with ILI. Nasopharyngeal aspirations were collected mainly from
immunocompromised patients with ALRTI complications and
required hospitalizations. A case of ILI was defined according to
PAHO/CDC guidelines for influenza surveillance as a progres-
sion of fever (.38uC) and either a symptom of cough, sore throat
or pharyngitis. Inclusion and exclusion criteria for ALRTI
patient enrolment have been described previously [20]. All
samples were collected in viral transport media with the addition
of antibiotics (2610
6 U/L of Penicillin G and 200 mg/l of
Streptomycin) and transported within 48 hours to the Center of
Excellence in Clinical Virology, Faculty of Medicine, Chula-
longkorn University, for routine respiratory virus diagnostic
testing. All respiratory specimens were divided into aliquots and
stored at 270uC until further tested. Children admitted multiple
times with more than one month between visits were considered
as separate illness episodes.
Ethical Consideration
This study was conducted on specimens collected upon
conclusion of routine examinations and stored as anonymous.
Permission had been granted by the Director of Chulalongkorn
King Memorial hospital. Patient identifiers including personal
information (name, address) and hospitalization number were
removed from these samples to protect patient confidentiality and
neither did they appear in any part of document in this study. The
research protocol was approved by the Institutional Review Board
(IRB number 329/54), Faculty of Medicine, Chulalongkorn
University. IRB waived the need for consent because the samples
were de-identified.
Laboratory Diagnosis for Virus-associated ARTI
Viral nucleic acid was extracted from clinical specimens using a
96-well viral nucleic acid extraction kit (RBC Bioscience, Taiwan).
cDNA synthesis was achieved with the M-MLV reverse-transcrip-
tion system (Promega, US) and random hexamer primers
according to the manufacturer’s recommendation. Each specimen
was tested for common respiratory viruses including RSV-A and
RSV-B, Flu-A (pH1N1/2009, seasonal H3 and H1) and Flu-B
[44]. For RV-EV screening, semi-nested PCR using a primer set
covering the 59UTR/VP2 region was performed as described
elsewhere [20]. The final PCR product of the specimens in which
RV implicated was ,540 nt in length. According to the close
relationship between RV and EV genome sequences, samples that
contained EV could be identified ,650 nt. The PCR products
were purified using the PCRExtract&GelExtract Mini Kits
(5PRIME, Germany) and sequenced bi-directionally by an
automated sequencer (First BASE Laboratories, Malaysia). EV68
implicated specimens were confirmed by performing PCR
amplifications of the VP1 gene as previously described [13].
Sequence Analysis
Sequence data for each clinical strain was formatted and
assembled by Seqman program of DNASTAR Software (v5.0). To
study the distribution and diversity of EV68 identified in this study
compared to other EVs, nucleotide sequences of the 59UTR/VP2
were multiple aligned by using ClustalW implemented in the
Bioedit program (v7.0.9). Phylogenetic trees were constructed by
neighbor-joining (NJ) method implemented in the MEGA
program (v5). The reliability of the NJ tree was estimated using
1000 bootstrap pseudo-replications. Phylogenetic distance among
sequences was measured using Kimura’s two-parameter model.
Meteorological Data
The climate of Thailand is tropical savanna with 3 different
seasons including winter (mid-November to mid-February),
summer (mid-February to mid-May), and rainy (mid-May to
mid-October). Bangkok meteorological data during the study
period were provided by the Thailand Meteorology Department
(http://www.tmd.go.th/en/). Meteorological data including tem-
perature (degree Celsius (uC)), rainfall (millimeter), and relative
humidity (%) were routinely measured at 3-hour intervals in the
Bangkok metropolis (standard code 455201) at latitude 13.43.35uN
and longitude 100.33.36uE. To determine whether the meteoro-
logical factors have an impact on or are associated with EV68
emergences in Thailand, bivariate analysis using 2-tailed Spear-
man’s coefficient (rs) were conducted using SPSS software (v17.0)
(Chicago, USA).
Sequence Dataset Preparation
Datasets of the VP1 gene were constructed to perform the
Bayesian phylogenetic investigations for estimating the divergence
time and determining TMRCA of the recently circulating EV68
lineages. Nucleotide datasets of the VP1 gene were established as
follows: dataset 1 was formed by including almost all available
EV68-VP1 sequences retrieved from GenBank database by
October 31, 2011 and additional nucleotide sequences identified
in this study (EV68-TH strains). The homologous sequences of
other EVs comprising EV94 for species D (n=2), CA-A10, EV90
and EV76 as a representative of species A (n=4) were included in
this data set. EV species B and C were assigned as outgroup. Each
isolate was labeled with its corresponding year of sampling or
isolating. In addition, an alignment of data set 1 containing 122
sequences corresponding to the VP1 gene was constructed
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The total sequence number of this dataset was 106 sequences with
the same length as data set 1.
Estimated Rate of Evolution and Divergence Time of the
Recent Spread of EV68
The rate of substitutions and divergence time of EV68 were
estimated by using a Bayesian MCMC approach as implemented
in the Bayesian Evolutionary Sampling Tree (BEAST) package
(v1.6.2) [45]. The best fit substitution model was chosen by
performing a maximum likelihood analysis using the Modeltest
package (v3.7) [46]. The best fit model suitable for calculation of
nucleotide substitutions was General Time Reversible (GTR)+I
(proportion of Invariant site)+G( c–distribution) model, allowing
for nucleotide rates to vary among sites within the capsid coding
sequence alignments. Alignments were performed by keeping the
first and second codon positions in one partition and the third
position in a separate partition as (1+2)+3 codon partitions. In
order to accommodate rate variation at the third codon position,
the relative rate parameter was separately estimated in each
partition.
Relaxed lognormal molecular clocks were employed and
followed by allowing substitution rate variations among branches
on the trees. Molecular model specification was selected using
Bayes Factors and used to quantitatively estimate the growth rate
and demographic parameter. The dynamic among study popula-
tions was estimated by performing a Bayesian Skyline plot. The
Bayesian MCMC chain lengths were 10 million generations with
sampling every 10000 generations and discarding 10% of the
chain as burn-in. Convergence of the chains was achieved by
computational run over a sufficient time with inspection of the
MCMC samples using TRACER (v1.4). The resulting tree of each
run was summarized using Tree Annotator and the maximum
clade credibility tree was visualized with FigTree software (v1.1.2).
Measurement of Selective Pressure on EV68
The value of v and the individual site specific selection pressure
were measured by using the likelihood based SLAC and FEL
contained in the HYPHY package. The database was accessed on
the website of Datamonkey interface (http://www.datamonkey.
org) [47]. The overall v value was estimated based on NJ trees
under the TrN93 substitution model. The significance level for a
positively selected site of SLAC and FEL analyses was accepted at
,0.1 (two-tailed binominal distribution). The relative residue
abundance within the BC and DE-surface exposed loops were
depicted by using WebLogo [48].
Statistical Analysis
Statistical data comparisons between various factors were
analyzed by means of Pearson x
2, unpaired T-test, or Fisher’s
exact test as appropriate, using SPSS software. All data were
considered statistically significant at a p-value below 0.05.
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